Abstract:Highlights • Synthetic lethality offers a promising means for expanding drug target space for cancer treatment. • We developed a knowledge and data dual-driven AI framework for synthetic lethality prediction (KDDSL). • KDDSL is a "visible" AI framework that integrates domain knowledge to explore synthetic lethality and its implications in cancer treatment. This "visible" framework enhances the trust between biologists and AI. • KDDSL can help in identifying SL interactions and guiding the design of synergistic anti-cancer combination therapies. • By applying KDDSL, we identified the combination of MDM2 and CDK9 inhibitors, which demonstrated significant anticancer effects in vitro and in vivo. Introduction Synthetic lethality (SL) provides an opportunity to leverage different genetic interactions when designing synergistic combination therapies. To further explore SL-based combination therapies for cancer treatment, it is important to identify and mechanistically characterize more SL interactions. Artificial intelligence (AI) methods have recently been proposed for SL prediction, but the results of these models are often not interpretable such that deriving the underlying mechanism can be challenging. Objectives This study aims to develop an interpretable AI framework for SL prediction and subsequently utilize it to design SL-based synergistic combination therapies. Methods We propose a knowledge and data dual-driven AI framework for SL prediction (KDDSL). Specifically, we use gene knowledge related to the SL mechanism to guide the construction of the model and develop a method to identify the most relevant gene knowledge for the predicted results. Results Experimental and literature-based validation confirmed a good balance between predictive and interpretable ability when using KDDSL. Moreover, we demonstrated that KDDSL could help to discover promising drug combinations and clarify associated biological processes, such as the combination of MDM2 and CDK9 inhibitors, which exhibited significant anti-cancer effects in vitro and in vivo . Conclusion These data underscore the potential of KDDSL to guide SL-based combination therapy design. There is a need for biomedicine-focused AI strategies to combine rational biological knowledge with developed models. Graphical abstract KDDSL open the black box of neural network to achieve interpretable prediction of SL (The two shields represent two SL genes). This can help us utilize SL to kill cancer cell. Download : Download high-res image (92KB) Download : Download full-size image

Predicting essential genes and synthetic lethality via influence propagation in signaling pathways of cancer cell fates.

Computational methods, databases and tools for synthetic lethality prediction

Meta-analysis of Genomic and Proteomic Features to Predict Synthetic Lethality of Yeast and Human Cancer.

Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer

Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network

Link Synthetic Lethality to Drug Sensitivity of Cancer Cells.

Ranking Novel Cancer Driving Synthetic Lethal Gene Pairs Using TCGA Data

SL2MF: Predicting Synthetic Lethality in Human Cancers Via Logistic Matrix Factorization

SL$^2$MF: Predicting Synthetic Lethality in Human Cancers via Logistic Matrix Factorization

Synthetic Lethality: a Promising Therapeutic Strategy for Hepatocellular Carcinoma.

SL-BioDP: Multi-Cancer Interactive Tool for Prediction of Synthetic Lethality and Response to Cancer Treatment

CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference

Systematic Analysis of Cancer-Specific Synthetic Lethal Interactions Provides Insight into Personalized Anticancer Therapy.

SLGNNCT: Synthetic Lethality Prediction Based on Knowledge Graph for Different Cancers Types

The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy

EXP2SL: A Machine Learning Framework for Cell-Line-Specific Synthetic Lethality Prediction.

Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis

Harnessing synthetic lethality to predict the response to cancer treatment

An interpretable artificial intelligence framework for designing synthetic lethality-based anti-cancer combination therapies

ELISL: early-late integrated synthetic lethality prediction in cancer

Synthetic lethal connectivity and graph transformer improve synthetic lethality prediction